These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11569243)

  • 21. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects.
    Nishimura K; Matsumiya K; Tsuboniwa N; Yamanaka M; Koga M; Miura H; Tsujimura A; Uchida K; Kondoh N; Kitamura M; Okuyama A
    Arch Androl; 1999; 43(3):207-13. PubMed ID: 10624504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
    Ryu K; Yu HK; Kwak HM; Hong SS
    Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization.
    Wu E; Xiao B; Yan W; Li H; Wu B
    Contraception; 1992 Jun; 45(6):583-93. PubMed ID: 1617967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal consequences of "missing the pill".
    Wang E; Shi S; Cekan SZ; Landgren BM; Diczfalusy E
    Contraception; 1982 Dec; 26(6):545-66. PubMed ID: 6820336
    [No Abstract]   [Full Text] [Related]  

  • 30. A Clinical Conundrum: Chronic Cervicitis.
    Hester EE; Middleman AB
    J Pediatr Adolesc Gynecol; 2019 Jun; 32(3):342-344. PubMed ID: 30582974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
    Farkas M
    Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission.
    Morris SE; Groom GV; Cameron ED; Buckingham MS; Everitt JM; Elstein M
    Contraception; 1979 Jul; 20(1):61-9. PubMed ID: 477318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reaction of the vaginal flora to ornidazol in patients with cervicitis.
    Lindner JG; Plantema FH; de Vos NM; Hoogkamp-Korstanje AA
    Chemotherapy; 1979; 25(4):243-8. PubMed ID: 456078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal status of patients with uterine cancer during surgical treatment].
    Musina RKh; Kiseleva NS; Modnikov OP
    Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P; Morer F; Ordoñez J; Rodriguez J
    Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.